Zimmer Biomet Holdings (ZBH) Asset Utilization Ratio (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Asset Utilization Ratio came in at 0.37 in Q1 2026, down 82.13% year-on-year from 2.05 in Q1 2025, and down 39.41% quarter-over-quarter from 0.61 in Q4 2025.
Zimmer Biomet Holdings (ZBH) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Asset Utilization Ratio history runs 18 years deep, the most recent figure standing at 0.37 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 82.13% year-over-year to 0.37 in Q1 2026; TTM through Mar 2026 was 0.37, a 82.13% decrease from a year earlier, with the FY2025 full-year figure at 0.61, up 0.82% from the prior year.
- Asset Utilization Ratio fell to 0.37 in Q1 2026 per ZBH's latest filing, from 0.61 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 2.05 in Q1 2025 and bottomed at 0.31 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 0.35 (2024), against an average of 0.69.
- Across the five-year window, Asset Utilization Ratio soared 492.07% in 2025 and slumped 82.13% in 2026, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.56 in 2022, then slumped by 37.98% to 0.35 in 2023, then soared by 74.38% to 0.6 in 2024, then climbed by 0.35% to 0.61 in 2025, then tumbled by 39.41% to 0.37 in 2026.
- Per Business Quant, the three latest ZBH Asset Utilization Ratio figures stand at 0.37 (Q1 2026), 0.61 (Q4 2025), and 1.97 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | 0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | 0.61 |
| Sep 30, 2025 | 1.97 |
| Jun 30, 2025 | 2.00 |
| Mar 31, 2025 | 2.05 |
| Dec 31, 2024 | 0.60 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.35 |
| Mar 31, 2024 | 0.35 |
| Dec 31, 2023 | 0.35 |
| Sep 30, 2023 | 0.34 |
| Jun 30, 2023 | 0.34 |
| Mar 31, 2023 | 0.57 |
| Dec 31, 2022 | 0.56 |
| Sep 30, 2022 | 0.32 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.31 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.30 |
| Jun 30, 2021 | 0.31 |